T. Rowe Price Associates’s LifePoint Health, Inc. LPNT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
-22,098
Closed -$1.42M 2653
2018
Q3
$1.42M Sell
22,098
-454,413
-95% -$27.7M ﹤0.01% 1723
2018
Q2
$23.3M Sell
476,511
-319,790
-40% -$16.6M ﹤0.01% 1157
2018
Q1
$37.4M Sell
796,301
-4,804
-0.6% -$231K 0.01% 969
2017
Q4
$39.9M Buy
801,105
+8,355
+1% +$415K 0.01% 951
2017
Q3
$45.9M Buy
792,750
+8,151
+1% +$485K 0.01% 878
2017
Q2
$52.7M Buy
784,599
+3,572
+0.5% +$226K 0.01% 799
2017
Q1
$51.2M Sell
781,027
-18,322
-2% -$1.13M 0.01% 798
2016
Q4
$45.4M Sell
799,349
-1,010
-0.1% -$58.4K 0.01% 839
2016
Q3
$47.4M Sell
800,359
-10,140
-1% -$608K 0.01% 824
2016
Q2
$53M Sell
810,499
-14,996
-2% -$1.02M 0.01% 758
2016
Q1
$57.2M Sell
825,495
-6,490
-0.8% -$433K 0.01% 719
2015
Q4
$61.1M Sell
831,985
-78,512
-9% -$5.58M 0.01% 699
2015
Q3
$64.6M Buy
910,497
+3,570
+0.4% +$290K 0.01% 698
2015
Q2
$78.9M Sell
906,927
-300
-0% -$22.7K 0.02% 679
2015
Q1
$66.6M Sell
907,227
-12,537
-1% -$890K 0.01% 743
2014
Q4
$66.1M Sell
919,764
-88,963
-9% -$6.16M 0.01% 741
2014
Q3
$69.8M Sell
1,008,727
-172,000
-15% -$12.1M 0.02% 714
2014
Q2
$73.3M Buy
1,180,727
+207,410
+21% +$12.2M 0.02% 727
2014
Q1
$53.1M Sell
973,317
-4,110
-0.4% -$220K 0.01% 845
2013
Q4
$51.6M Sell
977,427
-1,960
-0.2% -$98.4K 0.01% 823
2013
Q3
$45.7M Sell
979,387
-4,150
-0.4% -$199K 0.01% 845
2013
Q2
$48M Buy
+983,537
New +$47.2M 0.01% 797

Other funds holding LPNT

T. Rowe Price Associates's LPNT Position: Q4 2018 in Review

T. Rowe Price Associates sold out of LifePoint Health, Inc. (LPNT) in Q4 2018, closing a stake of 22,098 shares — an estimated $1.42M sold.

T. Rowe Price Associates first reported a position in LPNT in Q2 2013 and held it in 22 quarters. The position peaked at $78.9M in Q2 2015. 3 funds tracked by Wall St. Rank hold LPNT as of Q4 2018.

  • T. Rowe Price Associates reported no remaining LifePoint Health, Inc. position as of Q4 2018 after selling out during the quarter.
  • T. Rowe Price Associates sold 22,098 LifePoint Health, Inc. shares in Q4 2018, an estimated $1.42M.
  • T. Rowe Price Associates first reported a position in LifePoint Health, Inc. in Q2 2013 and held it in 22 quarters.
  • T. Rowe Price Associates's LifePoint Health, Inc. position peaked at $78.9M in Q2 2015.
  • 3 funds tracked by Wall St. Rank held LifePoint Health, Inc. as of Q4 2018.

Based on T. Rowe Price Associates's 13F filing for Q4 2018, filed 14 Feb 2019.